BR9807230A - 5-aminoalcóxi-1,4-diidroquinoxalina-2,3-dionas que são agonistas de dopamina - Google Patents

5-aminoalcóxi-1,4-diidroquinoxalina-2,3-dionas que são agonistas de dopamina

Info

Publication number
BR9807230A
BR9807230A BR9807230-7A BR9807230A BR9807230A BR 9807230 A BR9807230 A BR 9807230A BR 9807230 A BR9807230 A BR 9807230A BR 9807230 A BR9807230 A BR 9807230A
Authority
BR
Brazil
Prior art keywords
dihydroquinoxaline
aminoalkoxy
diones
dopamine agonists
dopamine
Prior art date
Application number
BR9807230-7A
Other languages
English (en)
Inventor
James Albert Nelson
Uresh Shantilal Shah
Richard Eric Mewshaw
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9807230A publication Critical patent/BR9807230A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"5-AMINOALCóXI-1,4-DIIDROQUINOXALINA-2,3-DIONAS QUE SãO AGONISTAS DE DOPAMINA"<D>. A presente invenção refere-se a compostos de Fórmula (I) em que: R^ 1^ e R^ 2^ são independentemente selecionados dentre hidrogênio, grupo alquila de cadeia linear e ramificada, com até 10 átomos de carbono ou -(CH~ 2~)~ m~Ar, onde Ar é fenila, naftila ou tienila, cada um sendo opcionalmente substituído com um ou dois substituintes selecionados independentemente dentre C~ 1-6~ alquila, halogênio, C~ 1-6~ alcóxido e trifluormetila; ou NR^ 1^R^ 2^ é 1, 2, 3, 4-tetrahidroquinolin-1-il ou 1,2,3,4-tetrahidroisoquinolin-2-il; m é 1-5; n é 1 ou 2; Y é halogênio, C~ 1-6~ alquila e C~ 1-6~ alcóxi; ou um sal farmaceuticamente aceitável destes, os quais se tratam de agonistas D~ 2~ de dopamina e, portanto, são de utilidade no tratamento de psicose e doenças de Parkinson.
BR9807230-7A 1997-02-18 1998-01-13 5-aminoalcóxi-1,4-diidroquinoxalina-2,3-dionas que são agonistas de dopamina BR9807230A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80132497A 1997-02-18 1997-02-18
PCT/US1998/001170 WO1998035948A1 (en) 1997-02-18 1998-01-13 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists

Publications (1)

Publication Number Publication Date
BR9807230A true BR9807230A (pt) 2000-04-25

Family

ID=25180799

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807230-7A BR9807230A (pt) 1997-02-18 1998-01-13 5-aminoalcóxi-1,4-diidroquinoxalina-2,3-dionas que são agonistas de dopamina

Country Status (14)

Country Link
EP (1) EP0963372A1 (pt)
JP (1) JP2001511805A (pt)
KR (1) KR20000071162A (pt)
CN (1) CN1248249A (pt)
AR (1) AR011669A1 (pt)
AU (1) AU722616B2 (pt)
BR (1) BR9807230A (pt)
CA (1) CA2278757A1 (pt)
HU (1) HUP0001311A3 (pt)
IL (1) IL131160A0 (pt)
NZ (1) NZ336971A (pt)
TW (1) TW434230B (pt)
WO (1) WO1998035948A1 (pt)
ZA (1) ZA981306B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329698B2 (en) 2008-06-16 2012-12-11 MERCK Patent Gesellschaft mit beschränkter Haftung Quinoxalinedione derivatives which are activators of AMPK-activated protein kinase

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK715888D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
US4975430A (en) * 1989-06-16 1990-12-04 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University CNQX and its analogs as therapeutics for degenerative neural diseases
PT99864B (pt) * 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
US5159083A (en) * 1990-12-28 1992-10-27 Neurogen Corporation Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
EP0647137B1 (en) * 1992-06-22 2008-08-13 The Regents Of The University Of California Glycine receptor antagonists and the use thereof
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
ES2169102T3 (es) * 1994-10-14 2002-07-01 Merck Patent Gmbh (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists

Also Published As

Publication number Publication date
HUP0001311A2 (hu) 2001-05-28
CA2278757A1 (en) 1998-08-20
AU6035098A (en) 1998-09-08
TW434230B (en) 2001-05-16
ZA981306B (en) 1999-08-17
EP0963372A1 (en) 1999-12-15
KR20000071162A (ko) 2000-11-25
JP2001511805A (ja) 2001-08-14
NZ336971A (en) 2000-10-27
AR011669A1 (es) 2000-08-30
CN1248249A (zh) 2000-03-22
WO1998035948A1 (en) 1998-08-20
HUP0001311A3 (en) 2001-07-30
AU722616B2 (en) 2000-08-10
IL131160A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
BRPI0514632A (pt) derivados de ftalazinona 4-heteroarilmetila substituìdos
HUP0303296A2 (hu) Karboxamidszármazékok és ezek alkalmazása tromboembóliás betegségek és tumorok kezelésére, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BR0208805A (pt) Uso de um derivado de pirazolina
BRPI0718966B8 (pt) composto, composição farmacêutica, inibidor plk1 e agente antitumoral
EA200400006A1 (ru) Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов
BR9916781A (pt) 4-oxo-1,4-dihidro-3-quinolinacarboxamidas comoagentes antivirais
BRPI0414738A (pt) derivados de ácido acético substituìdos
DE60236719D1 (de) Purinderivate als antagonisten an purinergen rezeptoren
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
MXPA04000532A (es) Derivados de 8-metoxi-(1,2,4)-triazolo(1,5-a)piridina y su uso como ligandos receptores de adenosina.
TW200716650A (en) Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency
SE8600913D0 (sv) Kemiska foreningar
CY1105330T1 (el) Καρβαμιδικα παραγωγα για χρηση στην προληψη ή την αγωγη της διπολικης διαταραχης
NZ336189A (en) Diaza-spiro[3,5]nonane derivatives and use in treatment of diseases related to the orphanin receptor
HUP0301587A2 (hu) Foszfodiészteráz V gátló hatású 5-amino-alkil-pirazolo[4,3-d]pirimidinek, ezeket tartalmazó gyógyszerkészítmények és eljárások az elżállításaikra
WO2009028387A1 (ja) プロテアーゼ阻害剤耐性を有する癌の治療薬
BRPI0416678A (pt) pirazolpirimidinas
BR0213177A (pt) Derivados de 5-metóxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
BR9807230A (pt) 5-aminoalcóxi-1,4-diidroquinoxalina-2,3-dionas que são agonistas de dopamina
HUP0203603A2 (hu) Új IL-8 receptor antagonista hatású indolszármazékok és ezeket tartalmazó gyógyszerkészítmények
EA200400770A1 (ru) Производные 5-(пиридин-3-ил)-1-азабицикло[3.2.1]октана, их получение и применение в терапии
HUP0301258A2 (hu) Aminoizokinolincsoportot tartalmazó trombin inhibitorok és alkalmazásuk gyógyszerkészítmények előállítására
HUP0001010A2 (hu) Benzimidazol-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
ATE380810T1 (de) Protein-tyrosine-kinase-inhibitoren
ATE238300T1 (de) (3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl)-3-(1 - indol-3-yl)-alkylamine

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]